Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label Tamoxifen. Show all posts
Showing posts with label Tamoxifen. Show all posts
Tuesday, May 22, 2012

case report - Granulosa cell tumor of the ovary after long-term use of tamoxifen and toremifene - Journal of Obstetrics and Gynaecology Research

›
Granulosa cell tumor of the ovary after long-term use of tamoxifen and toremifene - Tanaka - 2012 - Journal of Obstetrics and Gynaecology Re...
Tuesday, March 06, 2012

JNCI Commentary (open access): CYP2D6 Genotype as a Marker for Benefit of Adjuvant Tamoxifen in Postmenopausal Women: Lessons Learned

›
Blogger's Note: see extensive references including current papers regarding this issue  "Since 2003, there has been considerable...
Sunday, March 06, 2011

10-year analysis of the ATAC trial: wrong conclusion? : The Lancet Oncology

›
"The 10-year analysis of the Arimidex, Tamoxifen, Alone or in Combination (ATAC) trial1 continues to show a difference in its primary e...
Sunday, February 20, 2011

Undetectable antimüllerian hormone levels and recovery of chemotherapy-induced ovarian failure in women with breast cancer on an oral aromatase inhibitors

›
Abstract OBJECTIVE: Knowledge of the menopause status of a woman with breast cancer is important for good clinical practice. Long-lasti...
Sunday, February 13, 2011

full free access: Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial

›
Wednesday, January 12, 2011

full free access The Lancet: Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial : The Lancet Oncology

›
Saturday, October 02, 2010

abstract: Managing menopausal symptoms and depression in tamoxifen users: Implications of drug and medicinal interactions

›
OBJECTIVE: Tamoxifen, a medication used in the treatment of breast cancer, often induces menopausal symptoms. Certain medications and n...
Saturday, September 18, 2010

Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a complete response to first-line platinum/taxane chemotherapy with an evaluation of serum vascular endothelial growth factor

›
Conclusion Thalidomide was not more effective than tamoxifen in delaying recurrence or death but was more toxic. VEGF was not prognostic i...
Wednesday, September 01, 2010

EvidenceUpdates: Review: American society of clinical oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone recep

›
CONCLUSION The Update Committee recommends that postmenopausal women with hormone receptor-positive breast cancer consider incorporating AI ...
Monday, August 23, 2010

BioMed Central Blog : Does genetic test allow prediction of patients’ response to tamoxifen?

›
Wednesday, July 07, 2010

Testing for CHEK2 in the cancer genetics clinic: ready for prime time?

›
Abstract Narod SA. Testing for CHEK2 in the cancer genetics clinic: ready for prime time? The 1100delC mutation of the CHEK2 gene was ...
Tuesday, June 22, 2010

Abstract/free full text - Associations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancer

›
" Conclusions We have shown an association between tamoxifen and its metabolites and estrogen serum levels. An impact of CYP2C19 pred...
Wednesday, June 09, 2010

Paradigm Change Suggested for Ovarian Cancer

›
Note: this website requires registration/free "Women with biochemically recurrent ovarian cancer who take tamoxifen can gain an addi...
Thursday, April 01, 2010

Best Evidence Interview: Use of Some SSRIs With Tamoxifen Increases Mortality in Breast Cancer Patients: A Best Evidence Interview With Catherine Kelly, MD

›
Note: included in interview is discussion of U.S./Canadian/Global research on this subject matter (reminder: Medscape articles are freely a...
Tuesday, March 30, 2010

Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial

›
Friday, March 19, 2010

Tamoxifen for relapse of ovarian cancer. Cochrane Collaboration review (abstract)

›
AUTHORS' CONCLUSIONS: We are unable to make any evidence-based recommendations as we found no comparative studies assessing the effecti...
Thursday, February 18, 2010

YouTube - Insidermedicine In Depth - February 8, 2010 - combination Paxil/Tamoxifen + clinical commentary

›
Tuesday, February 09, 2010

news item: Paxil Blocks Tamoxifen Lowers Survival Odds Against Breast Cancer - Breast Cancer

›
"Patients taking Paxil and tamoxifen should talk with their doctors about changing their antidepressant, Juurlink said. But he advised ...